Cargando…

MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases

Neurodegenerative diseases are debilitating and currently incurable conditions causing severe cognitive and motor impairments, defined by the progressive deterioration of neuronal structure and function, eventually causing neuronal loss. Understand the molecular and cellular mechanisms underlying th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Catanesi, Mariano, d’Angelo, Michele, Tupone, Maria Grazia, Benedetti, Elisabetta, Giordano, Antonio, Castelli, Vanessa, Cimini, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504116/ https://www.ncbi.nlm.nih.gov/pubmed/32825273 http://dx.doi.org/10.3390/ijms21175986

Ejemplares similares

A State-of-the-Art of Functional Scaffolds for 3D Nervous Tissue Regeneration
por: Tupone, Maria Grazia, et al.
Publicado: (2021)

Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
por: Catanesi, Mariano, et al.
Publicado: (2021)

The Role of Stiffness in Cell Reprogramming: A Potential Role for Biomaterials in Inducing Tissue Regeneration
por: d’Angelo, Michele, et al.
Publicado: (2019)

An Update on Graphene-Based Nanomaterials for Neural Growth and Central Nervous System Regeneration
por: Tupone, Maria Grazia, et al.
Publicado: (2021)

L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson’s Disease
por: Catanesi, Mariano, et al.
Publicado: (2021)

Neuronal Cells Rearrangement During Aging and Neurodegenerative Disease: Metabolism, Oxidative Stress and Organelles Dynamic
por: Castelli, Vanessa, et al.
Publicado: (2019)

The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease?
por: Castelli, Vanessa, et al.
Publicado: (2020)

S-Carboxymethyl Cysteine Protects against Oxidative Stress and Mitochondrial Impairment in a Parkinson’s Disease In Vitro Model
por: Catanesi, Mariano, et al.
Publicado: (2021)

Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs
por: d’Angelo, Michele, et al.
Publicado: (2019)

The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells
por: Antonosante, Andrea, et al.
Publicado: (2018)

PPARs and Energy Metabolism Adaptation during Neurogenesis and Neuronal Maturation
por: D’Angelo, Michele, et al.
Publicado: (2018)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease models
por: Antonosante, Andrea, et al.
Publicado: (2023)

Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models
por: Castelli, Vanessa, et al.
Publicado: (2020)

Corrigendum: Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2020)

Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2019)

PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress
por: Castelli, Vanessa, et al.
Publicado: (2021)

The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death
por: Castelli, Vanessa, et al.
Publicado: (2021)

DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain
por: Brandolini, Laura, et al.
Publicado: (2019)

Probiotic DSF counteracts chemotherapy induced neuropathic pain
por: Castelli, Vanessa, et al.
Publicado: (2018)

Looking for In Vitro Models for Retinal Diseases
por: Alfonsetti, Margherita, et al.
Publicado: (2021)

Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
por: d’Angelo, Michele, et al.
Publicado: (2020)

Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky Gut
por: d’Angelo, Michele, et al.
Publicado: (2023)

Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics
por: Antonosante, Andrea, et al.
Publicado: (2020)

Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment
por: Fidoamore, Alessia, et al.
Publicado: (2017)

NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes
por: Brandolini, Laura, et al.
Publicado: (2020)

Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease
por: D’Egidio, Francesco, et al.
Publicado: (2023)

CXCR1/2 pathways in paclitaxel-induced neuropathic pain
por: Laura, Brandolini, et al.
Publicado: (2017)

Inflammatory Bowel Disease: New Insights into the Interplay between Environmental Factors and PPARγ
por: Caioni, Giulia, et al.
Publicado: (2021)

Current and experimental therapeutics for Fabry disease
por: Castelli, Vanessa, et al.
Publicado: (2021)

Neuroprotective effects of human amniotic fluid stem cells‐derived secretome in an ischemia/reperfusion model
por: Castelli, Vanessa, et al.
Publicado: (2020)

Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain
por: Cuozzo, Mariarosaria, et al.
Publicado: (2021)

PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors
por: Benedetti, Elisabetta, et al.
Publicado: (2010)

Corrigendum to “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors”
por: Benedetti, Elisabetta, et al.
Publicado: (2019)

Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance
por: Fidoamore, Alessia, et al.
Publicado: (2016)

Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases
por: John, Albin, et al.
Publicado: (2020)

Dysregulation of MicroRNAs in cancer
por: Chen, Pai-Sheng, et al.
Publicado: (2012)

Taurine and oxidative stress in retinal health and disease
por: Castelli, Vanessa, et al.
Publicado: (2021)

CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
por: Castelli, Vanessa, et al.
Publicado: (2021)

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
por: Gentile, Giulia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_36fcbagfh6t01f56aal6bn29si